MEDIPOST Co., Ltd. (KOSDAQ:078160)
10,540
-150 (-1.40%)
Aug 29, 2025, 12:40 PM KST
MEDIPOST Revenue
MEDIPOST had revenue of 19.22B KRW in the quarter ending March 31, 2025, with 6.62% growth. This brings the company's revenue in the last twelve months to 71.85B, up 3.91% year-over-year. In the year 2024, MEDIPOST had annual revenue of 70.66B with 2.93% growth.
Revenue (ttm)
71.85B
Revenue Growth
+3.91%
P/S Ratio
5.05
Revenue / Employee
220.03M
Employees
328
Market Cap
364.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 70.66B | 2.01B | 2.93% |
Dec 31, 2023 | 68.64B | 4.44B | 6.92% |
Dec 31, 2022 | 64.20B | 9.34B | 17.03% |
Dec 31, 2021 | 54.86B | 6.23B | 12.82% |
Dec 31, 2020 | 48.62B | 2.81B | 6.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 4.30B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |